Egetis Therapeutics
Develops and commercializes treatments for serious and rare diseases.
EGTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0003815604
- LEI:
- 549300RZCKGWRUBPMY22
- Country:
- Sweden
- Address:
- Klara Norra Kyrkogata 26, 111 22 Stockholm
- Website:
- https://www.egetis.com/
- Sector:
- Manufacturing
Description
Egetis Therapeutics is an innovative and integrated pharmaceutical company focused on developing and commercializing treatments for serious and rare diseases with significant unmet medical needs. The company's strategy centers on advancing drug candidates through late-stage clinical development to market approval. Its primary asset, Emcitate (tiratricol), is a first-in-class drug candidate in late-stage development for the treatment of Monocarboxylate Transporter 8 (MCT8) deficiency, a rare congenital disorder of thyroid hormone transport.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-12-11 14:30 |
Resolutions from extraordinary general meeting in PledPharma AB (publ) held on …
|
English | 96.6 KB | ||
| 2020-11-30 14:30 |
Change in the number of shares and votes in PledPharma
|
English | 89.0 KB | ||
| 2020-11-30 14:30 |
Ändring av antalet aktier och röster i PledPharma
|
Swedish | 90.3 KB | ||
| 2020-11-27 09:18 | English | 34.9 KB | |||
| 2020-11-25 18:30 |
PledPharma tillförs 250 MSEK genom övertecknad företrädesemission och utnyttjad…
|
Swedish | 147.9 KB | ||
| 2020-11-25 18:30 |
PledPharma raises SEK 250 million in oversubscribed rights issue and utilized o…
|
English | 150.2 KB | ||
| 2020-11-23 14:26 | English | 34.6 KB | |||
| 2020-11-23 14:00 |
Klargörande gällande ägarförändringar i PledPharma
|
Swedish | 124.1 KB | ||
| 2020-11-23 14:00 |
Clarification regarding ownership changes in PledPharma
|
English | 121.3 KB | ||
| 2020-11-12 16:15 |
PledPharma offentliggör tilläggsprospekt
|
Swedish | 70.5 KB | ||
| 2020-11-12 16:15 |
PledPharma publishes a supplement to the prospectus
|
English | 143.3 KB | ||
| 2020-11-11 13:16 | English | 33.8 KB | |||
| 2020-11-11 08:00 | Swedish | 347.1 KB | |||
| 2020-11-11 08:00 | English | 655.8 KB | |||
| 2020-11-10 14:50 |
NOTICE TO ATTEND EXTRAORDINARY GENERAL MEETING IN PLEDPHARMA AB
|
English | 91.3 KB |
Automate Your Workflow. Get a real-time feed of all Egetis Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Egetis Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Egetis Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-09 | Yilmaz Mahshid | Other | Sell | 39,753 | 268,332.75 SEK |
| 2025-01-08 | Yilmaz Mahshid | Other | Sell | 98,567 | 653,499.21 SEK |
| 2025-01-07 | Yilmaz Mahshid | Other | Sell | 74,769 | 507,681.51 SEK |
| 2024-10-07 | Nicklas Westerholm | Other | Buy | 10,142 | 43,103.50 SEK |
| 2024-10-07 | Yilmaz Mahshid | Other | Buy | 10,000 | 42,250.00 SEK |
| 2023-07-07 | Henrik Krook | Other | Buy | 33,594 | 133,704.12 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 3,616 | 14,391.68 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 2,000 | 7,920.00 SEK |
| 2023-07-05 | Christian Sonesson | Other | Buy | 1,384 | 5,452.96 SEK |
| 2023-07-04 | Nicklas Westerholm | Other | Buy | 15,350 | 60,632.50 SEK |
Peer Companies
